Latest News
Alembic Pharmaceuticals enjoys Rs.800 crore Loan Facility from Various Banks
| ➡️ Get instant news updates on Whatsapp. Click here to join our Whatsapp Group. |
Alembic Pharmaceuticals limited has taken Rs.800 crore loan from various banks. CRISIL Ratings Limited (CRISIL) vide its letter dated 25th July, 2025, has reaffirmed its Credit Rating (CRISIL AA+/Stable) on Bank Loan facilities.
| S.No. | Bank Facility | Bank | Amount (Rs. in Crore) | Outstanding Rating |
|---|---|---|---|---|
| 1 | Cash Credit & Working Capital Demand Loan | HDFC Bank Limited | 200 | Crisil AA+/Stable |
| 2 | Cash Credit & Working Capital Demand Loan | Kotak Mahindra Bank Limited | 100 | Crisil AA+/Stable |
| 3 | Cash Credit & Working Capital Demand Loan | The Hongkong and Shanghai Banking Corporation Limited | 100 | Crisil AA+/Stable |
| 4 | Cash Credit & Working Capital Demand Loan | Axis Bank Limited | 100 | Crisil AA+/Stable |
| 5 | Cash Credit & Working Capital Demand Loan | Citibank N. A. | 100 | Crisil AA+/Stable |
| 6 | Working Capital Demand Loan | State Bank of India | 200 | Crisil AA+/Stable |
| Total | 800 |
Alembic Pharmaceuticals Limited is an Indian pharmaceutical major that manufactures and markets. India Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. Headquartered in Vadodara, Gujarat, the company derives a third of revenue of over $600 million from the India market.
